MoneyWorks4Me

Medicamen Biotech - Quaterly Results

29 May 2023 Evaluate
The turnover zoomed to Rs. 371.48 millions, up 63.26% for the March 2023 quarter as against Rs. 227.54 millions during the year-ago period.A good growth in profit of 46.97% reported to Rs. 40.46  millions over Rs. 27.53 millions of corresponding previous quarter.Operating profit for the quarter ended March 2023 rose to 71.15 millions as compared to 53.15 millions of corresponding quarter ended March 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 371.48 227.54 63.26 1378.84 1154.45 19.44 1378.84 1154.45 19.44
Other Income 3.46 3.38 2.37 24.62 17.20 43.14 24.62 17.20 43.14
PBIDT 71.15 53.15 33.87 266.09 252.74 5.28 266.09 252.74 5.28
Interest 8.58 5.64 52.13 29.23 14.01 108.64 29.23 14.01 108.64
PBDT 62.57 47.51 31.70 236.86 238.73 -0.78 236.86 238.73 -0.78
Depreciation 16.10 15.24 5.64 63.54 57.71 10.10 63.54 57.71 10.10
PBT 46.47 32.27 44.00 173.32 181.02 -4.25 173.32 181.02 -4.25
TAX 6.01 4.74 26.79 23.31 31.97 -27.09 23.31 31.97 -27.09
Deferred Tax -4.74 -0.61 677.05 -13.69 -7.80 75.51 -13.69 -7.80 75.51
PAT 40.46 27.53 46.97 150.01 149.05 0.64 150.01 149.05 0.64
Equity 126.51 122.17 3.55 126.51 122.17 3.55 126.51 122.17 3.55
PBIDTM(%) 19.15 23.36 -18.00 19.30 21.89 -11.85 19.30 21.89 -11.85
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..